CytomX Therapeutics, Inc.
USD3.85
+0.12 (+3.07%)
CEO
Sean A. McCarthy
IPO Date
2015-10-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.75
Prev. Close
$3.74
Day Low
$3.64
Day High
$3.88
52W Low
$1.72
52W High
$8.21
Market Cap
$0.62B
Volume
2.51M
| 2.7 |
| 31 Dec 2023 | FY | 100.0% | -0.6% | 1.2% | -0.3% | -0.29 | 1.17 | -201.1 |
| 31 Dec 2022 | FY | 100.0% | -186.8% | 115.8% | -38.1% | -0.21 | 1.55 | -1.1 |
| 31 Dec 2021 | FY | 100.0% | -310.5% | 25244.0% | -34.1% | -47.22 | 3.98 | -2.4 |
| 31 Dec 2020 | FY | 100.0% | -94.7% | 833.8% | -18.1% | -3.20 | 4.76 | -4.7 |
| 31 Dec 2019 | FY | 100.0% | -177.8% | -200.0% | -30.0% | 0.54 | 3.54 | -3.7 |
| 31 Dec 2018 | FY | 100.0% | -142.2% | -64.6% | -18.5% | 0.00 | 4.55 | -7.4 |
| 31 Dec 2017 | FY | 100.0% | -60.2% | -61.7% | -10.8% | 0.00 | 6.36 | -18.2 |
| 31 Dec 2016 | FY | 100.0% | -391.5% | -75.1% | -29.6% | 0.00 | 5.26 | -6.8 |
| -6.8 |
| 30 Sept 2025 | Q3 | 100.0% | -238.6% | -13.2% | -9.0% | 0.05 | 3.64 | -9.2 |
| 30 Jun 2025 | Q2 | 100.0% | -0.8% | -0.1% | -0.1% | 0.06 | 4.20 | -475.7 |
| 31 Mar 2025 | Q1 | 100.0% | 46.2% | 93.9% | 23.9% | 0.33 | 1.73 | 0.6 |
| 31 Dec 2024 | Q4 | 100.0% | 49.6% | -4139.5% | 15.7% | -20.58 | 1.25 | 1.1 |
| 30 Sept 2024 | Q3 | 100.0% | 17.2% | -24.5% | 4.1% | -0.45 | 1.04 | 4.4 |
| 30 Jun 2024 | Q2 | 100.0% | -26.0% | 20.9% | -4.1% | -0.38 | 1.00 | -4.3 |
| 31 Mar 2024 | Q1 | 100.0% | 33.3% | -43.5% | 7.5% | -0.41 | 1.16 | 3.2 |
| 31 Dec 2023 | Q4 | 100.0% | 3.1% | -1.8% | 0.4% | -0.29 | 1.17 | 31.2 |